Biohackr.Labs
CJC/Ipa Monthly Pen — label view01 / 02

PERFORM Protocol

CJC/Ipa Monthly Pen

CJC-1295 and Ipamorelin — compounding GH-axis support, monthly protocol.

Technical Specifications

Total Content
10 mg total blend
Fill Volume
2.0 mL
Concentration
2.5 + 2.5 mg/mL
Per Click
25 mcg + 25 mcg/click
Total Clicks
200
Collection
PERFORM

Key Attributes

  • Synergistic mechanism — GHRH + GHS combination for amplified, physiological GH pulses
  • Ipamorelin selectivity minimises cortisol and prolactin elevation
  • Supports recovery, body composition, sleep quality, and anti-aging goals
  • Monthly protocol in a single pen — no complex multi-compound administration
  • Available through private access in Bangkok — synergistic GH support without synthetic GH

Biohackr.Labs provides product education, protocol guidance, and private client support. Information on this website is not medical advice and does not replace consultation with a licensed healthcare professional.

Biohackr.Labs premium hard case open — precision pen and 10 individually sealed micro needles
Premium hard case open at angle — pen and needle kit in foam insert
Biohackr.Labs premium white hard case — closed with holographic logo

What's Included

Premium hard case.
Everything included.

Every Biohackr.Labs pen ships in our premium white hard case — holographic logo, foam-fitted interior. Inside: the precision pen, ten individually sealed 31G 8mm micro needles, and all documentation needed to begin your protocol correctly.

Precision pen

Pre-filled, batch quality-controlled pen system ready at your confirmed starting dose.

10× 31G micro needles

31G 8mm individually sealed sterile micro needles. Ten included as standard with every pen.

Protocol card

Starting dose, titration schedule, session guidance, and what to expect — specific to your protocol.

Batch QC documentation

Batch reference, preparation date, and compound specification. Not boilerplate — specific to your order.

Storage & handling guide

Temperature requirements, travel guidance, and handling notes with Bangkok climate context.

WhatsApp support access

Direct channel access throughout your protocol for questions, dose adjustments, and guidance.

Cold-Chain Delivery

Professionally packed
for Bangkok logistics.

Every Biohackr.Labs order is individually sealed, temperature-controlled, and dispatched in protective cold-chain packaging engineered to maintain product integrity from preparation to your door.

2–8°C maintained

Insulated inner liner and cold-pack keep the product in range throughout Bangkok transit.

Discreet outer packaging

Plain kraft outer box — no branding, no product name, no external indication of contents.

Tamper-evident sealing

Every product is individually sealed before dispatch. Integrity is visible at handover.

Biohackr.Labs temperature-controlled packaging — kraft shipping box open with insulated liner and sealed product inside
Biohackr.Labs temperature-controlled outer shipping box
Biohackr.Labs individually sealed product bag
Biohackr.Labs cold-chain packaging components — thermal liner, insulated bag, sealed product
Biohackr.Labs product in premium sealed shipping bag

Step 01

Protocol Overview

CJC-1295 and Ipamorelin — compounding GH-axis support, monthly protocol.

The CJC/Ipa Monthly Pen combines CJC-1295 (a modified GHRH analogue) and Ipamorelin (a selective GH secretagogue) in a single monthly pen — 10 mg total blend across 200 precision clicks. Together, these two compounds produce a compounding stimulus to endogenous growth hormone release: CJC-1295 extends the GH pulse duration while Ipamorelin amplifies the pulse magnitude, without the cortisol and appetite side effects associated with broader secretagogues like GHRP-6. A clean, synergistic GH-axis support protocol for clients in Bangkok and Thailand.

Step 02

Mechanism of Action

CJC-1295 is a GHRH analogue that stimulates the pituitary gland to release growth hormone in a manner that mimics the natural pulsatile pattern. Ipamorelin is a selective ghrelin receptor agonist that amplifies GH pulses without significantly affecting cortisol or prolactin levels. The combination produces a sustained, amplified GH pulse pattern — increasing endogenous GH output in a physiologically consistent manner. IGF-1 levels rise as a downstream result, mediating the recovery and anabolic effects.

Suggested Use

Daily subcutaneous administration. 1–2 clicks per session. Optimal administration time confirmed through private onboarding — typically before sleep for maximum GH pulse alignment.

Who This Protocol Is For

Designed for clients in Bangkok and Thailand seeking GH-axis support without synthetic HGH, or as a complementary protocol alongside other performance compounds. Suitable for clients who want sustained, physiological GH optimisation with a favourable side-effect profile.

Storage — Bangkok & Thailand

Refrigerate between 2–8°C. Peptide combination products maintain stability best under consistent cold storage. Avoid temperature fluctuation throughout the monthly protocol.

Private Access Required

All Biohackr.Labs protocols are guided through private client onboarding. Dosing and administration are confirmed per client before access is granted.

Enquire on WhatsApp

The Compound

What Is CJC-1295 + Ipamorelin?

GH Secretagogue Stack — Endogenous GH Stimulation

The CJC/Ipa Monthly Pen combines two complementary growth hormone secretagogues in a single monthly protocol: CJC-1295 (a modified GHRH analogue that extends the duration of GH pulses) and Ipamorelin (a selective ghrelin receptor agonist that amplifies the magnitude of GH pulses). Together, they produce a compounding stimulus to endogenous GH release — stimulating the pituitary to produce more of its own natural GH, rather than introducing exogenous GH. This is the key distinction: the CJC/Ipa protocol works through the body's own pituitary axis, maintaining more physiological GH patterns than direct HGH administration.

Mechanism of Action

How It Works

CJC-1295 is a modified version of growth hormone-releasing hormone (GHRH) — the hypothalamic signal that tells the pituitary to release GH. By extending the half-life of GHRH signalling, CJC-1295 prolongs the GH release window. Ipamorelin binds to ghrelin receptors in the pituitary, directly stimulating an additional GH pulse with high selectivity — unlike older secretagogues (GHRP-6, GHRP-2), it does not significantly raise cortisol or prolactin. The combination creates a dual-stimulus GH pulse: CJC-1295 extends the release window, Ipamorelin amplifies the peak. The result is sustained, amplified endogenous GH production that drives IGF-1 elevation as a downstream effect.

Evidence Level

Clinical evidence for individual components · Stack widely used in practice

Research Landscape

Individual components have published human data. CJC-1295 (with DAC) was studied in a Phase 1/2 clinical trial showing dose-dependent GH and IGF-1 elevation lasting 6 days per injection. Ipamorelin has demonstrated selective GH release without cortisol or prolactin elevation in clinical research. Combined CJC/Ipamorelin protocols are among the most commonly prescribed GH-axis therapies in concierge medicine globally. Wells Pharmacy Network — one of the US's major compounding pharmacies — has specifically webinarised CJC-1295/Ipamorelin as a standard clinical protocol. The combination is considered the "entry-level" GH optimization protocol before direct HGH.

Biohacking & Community Context

CJC-1295 + Ipamorelin is the most widely recommended "starter" GH axis protocol in the biohacking community — specifically because it works with the body's own GH production rather than replacing it. The selective nature of Ipamorelin (no cortisol, no prolactin spike) makes it far more comfortable than older secretagogues. Community-reported effects: improved deep sleep quality within 1–2 weeks (one of the most consistent early reports), gradual lean mass improvement, fat reduction, improved skin, and enhanced morning energy. Anti-aging clinics in Bangkok routinely prescribe CJC/Ipamorelin as a foundational protocol alongside testosterone optimization. The combination is particularly popular with men over 40 who want GH-axis support without the cost and complexity of HGH.

Protocol Benefits

Reported Benefits & Research Findings

Endogenous GH Stimulation

Works through the pituitary to amplify the body's own GH production — maintaining physiological pulsatile GH patterns rather than the continuous elevation of exogenous HGH.

Selective GH Release

Ipamorelin's selectivity is the key advantage over older secretagogues. No significant cortisol or prolactin elevation — making it well-tolerated and suitable for daily use without the stress hormone side effects of GHRP-6 or GHRP-2.

Deep Sleep Enhancement

The most consistently reported early effect in the biohacking community. Evening administration aligns with natural GH pulsatility — amplifying the deep sleep GH pulse that is responsible for much of the overnight recovery and repair process.

Body Composition Support

Through elevated IGF-1 as a downstream effect of GH stimulation: lean mass support, fat oxidation, and metabolic rate maintenance — the same benefits as HGH but achieved through endogenous production.

Bone & Connective Tissue

Long-term GH axis optimization supports bone density maintenance, collagen synthesis, and connective tissue integrity — relevant for men over 40 managing the structural effects of hormonal decline.

Research Data

Key Findings & Statistics

6 days

GH elevation per injection (CJC-1295 with DAC)

Phase 1/2 clinical trial showed GH elevation lasting up to 6 days per CJC-1295 (with DAC) injection — enabling weekly or bi-weekly dosing

CJC-1295 Phase 1/2 trial

No cortisol

Ipamorelin selectivity advantage

Unlike GHRP-6 and GHRP-2, Ipamorelin does not significantly raise cortisol or prolactin — the clinical advantage that made it the preferred secretagogue partner for CJC-1295

Clinical pharmacology data

1–2 weeks

Community-reported time to sleep improvement

Improved deep sleep quality is the most consistently reported early effect — typically noticed within 1–2 weeks of nightly administration before sleep

Biohacking community consensus

Monthly

Protocol duration in a single pen

The CJC/Ipa Monthly Pen provides a complete 30-day protocol in a single pen — CJC-1295 + Ipamorelin combined at 25 mcg + 25 mcg per click

Biohackr.Labs specifications

CJC-1295 (without DAC) and Ipamorelin are compounded peptides without FDA approval for optimization use. CJC-1295 with DAC has Phase 1/2 clinical data. Ipamorelin has clinical selectivity data. The combination is clinically used in concierge medicine worldwide with an established safety profile in clinical practice, though large-scale RCTs are not published for the specific combination.

Private Access

Premium imported peptide pens in Bangkok.

Private protocol access · European-sourced · Quality-controlled · Thailand delivery

Enquire About CJC/Ipa Monthly Pen
WhatsApp